RINALDI, FRANCESCO
 Distribuzione geografica
Continente #
AS - Asia 2.396
EU - Europa 1.384
NA - Nord America 1.296
SA - Sud America 183
Continente sconosciuto - Info sul continente non disponibili 82
AF - Africa 77
OC - Oceania 15
Totale 5.433
Nazione #
US - Stati Uniti d'America 1.232
CN - Cina 743
IT - Italia 680
SG - Singapore 606
VN - Vietnam 288
KR - Corea 184
IN - India 153
BR - Brasile 147
HK - Hong Kong 144
FR - Francia 138
DE - Germania 123
GB - Regno Unito 108
JP - Giappone 80
BD - Bangladesh 75
NL - Olanda 58
IE - Irlanda 44
CA - Canada 36
CH - Svizzera 34
TW - Taiwan 33
CI - Costa d'Avorio 29
AT - Austria 25
RU - Federazione Russa 25
ES - Italia 24
DK - Danimarca 19
FI - Finlandia 18
SE - Svezia 17
IR - Iran 15
AU - Australia 14
GR - Grecia 11
MX - Messico 10
PH - Filippine 10
PT - Portogallo 10
TH - Thailandia 10
TR - Turchia 10
AR - Argentina 9
ZA - Sudafrica 9
CZ - Repubblica Ceca 8
EC - Ecuador 8
ID - Indonesia 8
UA - Ucraina 8
EG - Egitto 7
MA - Marocco 7
SC - Seychelles 7
BE - Belgio 6
DZ - Algeria 6
PL - Polonia 6
SA - Arabia Saudita 6
CR - Costa Rica 5
HN - Honduras 5
RO - Romania 5
BG - Bulgaria 4
CL - Cile 4
IQ - Iraq 4
JO - Giordania 4
MY - Malesia 4
NG - Nigeria 4
PK - Pakistan 4
CO - Colombia 3
GT - Guatemala 3
IL - Israele 3
LV - Lettonia 3
NA - Namibia 3
PE - Perù 3
PY - Paraguay 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
HR - Croazia 2
LT - Lituania 2
NO - Norvegia 2
SI - Slovenia 2
TG - Togo 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
AZ - Azerbaigian 1
CY - Cipro 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GE - Georgia 1
GF - Guiana Francese 1
KH - Cambogia 1
KW - Kuwait 1
LB - Libano 1
ME - Montenegro 1
MW - Malawi 1
NP - Nepal 1
NZ - Nuova Zelanda 1
OM - Oman 1
PS - Palestinian Territory 1
SM - San Marino 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
VC - Saint Vincent e Grenadine 1
Totale 5.351
Città #
Singapore 468
Hefei 334
Ashburn 162
Bologna 159
Seoul 145
Hong Kong 120
San Jose 113
Milan 86
Santa Clara 82
Ho Chi Minh City 77
Hanoi 71
Council Bluffs 69
Beijing 56
Tokyo 55
Dublin 42
Bengaluru 40
Genoa 39
New York 35
Los Angeles 34
Abidjan 29
Lauterbourg 29
Boardman 27
Paris 26
Rome 24
Buffalo 22
Dallas 22
Hyderabad 20
Frankfurt am Main 19
São Paulo 19
The Dalles 17
Amsterdam 16
Modena 16
Vienna 16
Falkenstein 15
Haiphong 14
Nuremberg 14
Toronto 14
Zurich 14
Florence 13
Guangzhou 13
Houston 13
Taipei 13
Atlanta 12
Berlin 12
Chicago 12
Copenhagen 12
Helsinki 11
Munich 11
Nanjing 11
Philadelphia 11
Redondo Beach 11
Shanghai 11
Stockholm 11
Turin 11
London 10
Mainz 10
Naples 10
Tongling 10
Da Nang 9
Fano 9
Fiumalbo 9
Ithaca 9
Nerviano 9
Parma 9
Seattle 9
Washington 9
Yuseong-gu 9
Athens 8
Baltimore 8
Brooklyn 8
Brugherio 8
Cambridge 8
Johannesburg 8
Miami 8
North Charleston 8
Orem 8
Pesaro 8
St Louis 8
Wilmington 8
Chennai 7
Columbus 7
Edinburgh 7
Exeter 7
Forlì 7
Frederick 7
Hamburg 7
Leeds 7
Macerata 7
Mumbai 7
New Delhi 7
New Haven 7
Phoenix 7
Rimini 7
Rio de Janeiro 7
Southend 7
Ann Arbor 6
Biên Hòa 6
Carlsbad 6
Cento 6
Illkirch-Graffenstaden 6
Totale 3.107
Nome #
A RAD51/BRCA2 small molecule inhibitor enhances the antineoplastic effect of the PARPi talazoparib in pancreatic cancer 364
The mechanistic understanding of the BRCA2-RAD51 interaction: an integrated structural biophysics study 303
A journey through targeting BRCA2-RAD51 protein-protein interaction to establish synthetic lethality as paradigm for anticancer drug discovery 276
Insights into the activity of ARN24089, a new RAD51-BRCA2 disruptor that inhibits homologous recombination and achieves synthetic lethality in pancreatic cancer 264
New Horizons of Synthetic Lethality in Cancer: Current Development and Future Perspectives 254
Identification and subsequent development of RAD51-BRCA2 disruptors through a fragment-based approach 226
An integrative structural study of RAD52, an emerging target in anticancer drug discovery 221
Dissecting the BRCA2 - RAD51 interaction by integrating computational and experimental biophysics 214
An 19F NMR fragment-based approach for the discovery and development of BRCA2-RAD51 inhibitors to pursuit synthetic lethality in combination with PARP inhibition in pancreatic cancer 213
Elucidating the BRCA2-RAD51 interaction through an integrated biophysical and structural biology approach 205
Elucidating the BRCA2-RAD51 interaction through an integrated structural biophysics approach 201
Elucidating the BRCA2 - RAD51 interaction by integrating computational and experimental biophysics 188
Novel Insights into RAD52’s Structure, Function, and Druggability for Synthetic Lethality and Innovative Anticancer Therapies 186
Elucidating the RAD51-BRC repeats interaction by integrating computational and experimental approaches 186
The Mechanistic Understanding of RAD51 Defibrillation: A Critical Step in BRCA2-Mediated DNA Repair by Homologous Recombination 171
Isolation and Characterization of Monomeric Human RAD51: A Novel Tool for Investigating Homologous Recombination in Cancer 167
Elucidating RAD52 architecture through an integrated structural biology approach 167
Integration of computational and experimental biophysics reveals novel insights on the BRCA2 - RAD51 interaction 158
An integrative structural study of the human full-length RAD52 at 2.2 Å resolution 132
Probing the BRC repeats RAD51 interaction by integrating computational and experimental biophysics 132
Dissecting the RAD51-BRC4 Interaction Landscape through Integrative Molecular Simulations and Experimental Biophysics 121
Combining computational and experimental methods to characterize the RAD51-BRC repeats interaction 119
An integrated biophysical and structural biology approach to investigate the BRCA2-RAD51 interaction 113
Development of a novel fully-human anti-CD123 antibody to target acute myeloid leukemia 112
The mechanistic understanding of the BRCA2-RAD51 interaction: an integrated structural biophysics study 106
Unveiling the molecular mechanism of BRCA2-RAD51 interaction to tackle cancer onset 102
RAD51 nuclear recruitment and inhibition towards innovative strategies against pancreatic cancer 89
Structure-based approaches in synthetic lethality strategies 66
An integrative structural biology study of the RAD51–BRC repeats interplay in Homologous Recombination 58
A chemical biology probe identified through 19F NMR screening stimulates RAD51 oligomerization and disrupts BRC4 binding 55
null 51
Understanding how structure shapes the architecture of homologous recombination 50
Investigazione dell’interazione BRCA2-RAD51 50
Molecular determinants of the BRC Repeats - RAD51 recognition 46
A fragment identified by 19F NMR stabilizes RAD51 fibrils and antagonizes BRC4 binding 46
An integrated structural approach reveals novel insights on the BRCA2 - RAD51 interaction 21
Totale 5.433
Categoria #
all - tutte 12.436
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.436


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202243 0 0 19 0 3 1 1 8 0 1 6 4
2022/2023105 2 5 1 6 25 1 5 3 11 4 7 35
2023/2024588 69 58 24 53 74 42 48 37 17 24 62 80
2024/20251.303 77 78 86 53 148 64 70 129 90 68 82 358
2025/20263.033 312 429 279 359 249 96 232 133 445 148 158 193
2026/2027328 169 159 0 0 0 0 0 0 0 0 0 0
Totale 5.433